2022-501590-39-00招募中1 期
A study of ASP3082 in adults with advanced solid tumors
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 90
- 试验地点
- 9
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Trial Unit Head
Scientific
Astellas Pharma Inc
研究点 (9)
Loading locations...
相似试验
招募中
不适用
A study of ASP3082 in adults with advanced solid tumorsjRCT2031220738Astellas Pharma Inc.651
已完成
1 期
Phase I Study of TAS-115 in Patients with Advanced Solid TumorsjRCT2080222284Taiho Pharmaceutical Co., Ltd.90
未知
1 期
Phase I Study of TAS-115 in Patients with Advanced Solid TumorsjRCT2080221605Taiho Pharmaceutical Co., Ltd.85
招募中
1 期
A study of ASP3082 in adults with previously treated solid tumorsJPRN-jRCT2031220738Fujii Hisaki356
未知
不适用
A confirmatory study of APTA-2217 in adult patients with bronchial asthma (A placebo-controlled double-blind comparative study)Bronchial asthmajRCT2080220094Mitsubishi Tanabe Pharma was the original trial sponsor; however Astra Zeneca is now the Responsible Party